A mechanistic model and therapeutic interventions for COVID-19
LONG COVID”—A hypothesis for understanding the biological basis
My Experience Reporting on the COVID-19 Bradykinin Hypothesis
Lab experiments support COVID-19 bradykinin storm theory
Infographic: SARS-CoV-2 Interferes with Bradykinin Regulation
A historical perspective on ACE2 in the COVID-19 era
Hypothesis: Sex-Related Differences in ACE2 Activity May
A Novel Angiotensin Converting Enzyme 2 (ACE2) Activating Peptide
The dynamic changes in cytokine responses in COVID-19: a snapshot
Cell-Specific Mechanisms in the Heart of COVID-19 Patients
Frontiers Is Covid-19 Severity Associated With ACE2 Degradation?
Home as the new frontier for the treatment of COVID-19: the case
Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19